| MATERIAL S AND ME THODS

| Vitamin D GWAS dataset
We selected six genetic variants associated with circulating 25-hydroxyvitamin D (25OHD) levels at a genome-wide significant level (P < 5.00E-08) from a recent large-scale genome-wide association study (GWAS) dataset including 79 366 individuals of European descent. 7 All these six genetic variants were independent and not in linkage disequilibrium. Here, we selected these six genetic variants influencing 25OHD levels as the potential instrumental variables.
The summary results including the effect of each genetic variant on 25OHD levels and the standard errors are exacted from the recent study (Table 1) . 7 
| BMD GWAS datasets
The BMD GWAS dataset is from the GEnetic Factors for OSteoporosis (GEFOS) Consortium. 8 The dataset is a total body BMD GWAS including 66 628 individuals from multiple population-based cohorts across Europe (86%), America (2%) and Australia (14%). 8 Meanwhile,
single GWAS was performed in each of five age strata spanning 15 years including 0-15 years (n = 11 807), 15-30 years (n = 4180), 30-45 years (n = 10 062), 45-60 years (n = 18 805) and 60 or more years (N = 22 504). 
| Pleiotropy analysis
In 
| Mendelian randomization analysis
Here, we selected the inverse-variance weighted meta-analysis (IVW) as the main analysis method, and selected the weighted median regression and MR-Egger regression as the sensitivity analysis methods. 9 The odds ratio as well as 95% confidence interval of total body BMD corresponds to per 0.5-mg/dL increase (about 1 standard deviation) in vitamin D levels. All analyses were conducted using the R package 'Mendelian Randomization'. 10 The significance of statistically significant association between vitamin D levels and BMD was at Bonferroni corrected significance P < 0.05/6 = 0.00833.
| RE SULTS
| Association of vitamin D variants with BMD
Here, we extracted the summary statistics for all these six genetic variants in each of these six total body BMD GWAS datasets, respectively. Some of these six genetic variants were significantly associated with BMD at the Bonferroni corrected significance threshold (P < 0.05/6 = 0.0083) (Tables S1-S6) . 
TA B L E 1 Characteristics of six genetic variants with vitamin D levels
| Pleiotropy analysis
In stage 1, none of these six genetic variants was significantly associated with known confounders at the Bonferroni corrected significance threshold (P < 0.05/6 = 0.008 33), as described in Table S7 . In stage 2, using these six genetic variants, MR-Egger intercept test showed no significant intercept (all P > 0.05) in each of these six GWAS datasets (Table 2) . Hence, our following analysis will be based on these six genetic variants.
| Association of vitamin D levels with BMD
In the overall dataset and five age stratum datasets, IVW, weighted median regression and MR-Egger regression IVW did not show statistically significant association of genetically increased vitamin D levels with total body BMD at the Bonferroni corrected significance P < 0.05/6 = 0.008 33, as described in Table 2 . The leave-one-out permutation analysis further showed that the direction and precision of the genetic estimates between increased vitamin D levels and total body BMD remained largely unchanged.
| D ISCUSS I ON
Here, we performed a Mendelian randomization study, and identified no significant association of genetically increased vitamin D levels with BMD of total body in any age stratum. 
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